Eintrag weiter verarbeiten
Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation
Gespeichert in:
| Zeitschriftentitel: | Clinical Cardiology |
|---|---|
| Personen und Körperschaften: | , |
| In: | Clinical Cardiology, 7, 1984, 3, S. 163-170 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Johansson, P.‐A. Bertil OLSSON, S. Johansson, P.‐A. Bertil OLSSON, S. |
|---|---|
| author |
Johansson, P.‐A. Bertil OLSSON, S. |
| spellingShingle |
Johansson, P.‐A. Bertil OLSSON, S. Clinical Cardiology Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation Cardiology and Cardiovascular Medicine General Medicine |
| author_sort |
johansson, p.‐a. |
| spelling |
Johansson, P.‐A. Bertil OLSSON, S. 0160-9289 1932-8737 Wiley Cardiology and Cardiovascular Medicine General Medicine http://dx.doi.org/10.1002/clc.4960070306 <jats:title>Abstract</jats:title><jats:p>It has earlier been shown that verapamil given intravenously or orally in sufficiently high single doses, may result in regular ventricular rhythm in patients with atrial fibrillation. We have analyzed whether this effect of verapamil can be utilized in long‐term oral treatment. Eleven patients with lone atrial fibrillation were studied. Verapamil was given in gradually increasing doses from 40 mg three times a day to 320 mg three times a day, either alone or in combination with digoxin. Resting ECG was recorded and supine and standing blood pressures were measured on each dose level. When the patients were treated with verapamil alone, only a slight decrease in heart rate was noted, while during combined treatment with verapamil and digoxin a more marked heart rate decrease occurred with increasing doses of verapamil. The variation coefficient of the RR interval, a sign of ventricular regularity, decreased during verapamil treatment regardless of whether or not digoxin was also taken. A dose‐dependent blood pressure decrease was noted during verapamil treatment.</jats:p><jats:p>Side effects were common and led to discontinuation of the attempted protocol in all patients. Three patients were unexpectedly converted to stable sinus rhythm. Five patients improved subjectively, with a marked decrease in the sensation of palpitations during intake of increasing doses of verapamil. The study indicates that chronic oral treatment with verapamil may sometimes relieve the subjective sensation of palpitations in patients with atrial fibrillation. Side effects do, however limit the value of this mode of treatment in the majority of patients.</jats:p> Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation Clinical Cardiology |
| doi_str_mv |
10.1002/clc.4960070306 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9jbGMuNDk2MDA3MDMwNg |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9jbGMuNDk2MDA3MDMwNg |
| institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Rs1 DE-Pl11 DE-105 DE-14 DE-Ch1 DE-L229 |
| imprint |
Wiley, 1984 |
| imprint_str_mv |
Wiley, 1984 |
| issn |
0160-9289 1932-8737 |
| issn_str_mv |
0160-9289 1932-8737 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
johansson1984longtermoraltreatmentwithhighdosesofverapamilinloneatrialfibrillation |
| publishDateSort |
1984 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
Clinical Cardiology |
| source_id |
49 |
| title |
Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation |
| title_unstemmed |
Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation |
| title_full |
Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation |
| title_fullStr |
Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation |
| title_full_unstemmed |
Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation |
| title_short |
Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation |
| title_sort |
long‐term oral treatment with high doses of verapamil in lone atrial fibrillation |
| topic |
Cardiology and Cardiovascular Medicine General Medicine |
| url |
http://dx.doi.org/10.1002/clc.4960070306 |
| publishDate |
1984 |
| physical |
163-170 |
| description |
<jats:title>Abstract</jats:title><jats:p>It has earlier been shown that verapamil given intravenously or orally in sufficiently high single doses, may result in regular ventricular rhythm in patients with atrial fibrillation. We have analyzed whether this effect of verapamil can be utilized in long‐term oral treatment. Eleven patients with lone atrial fibrillation were studied. Verapamil was given in gradually increasing doses from 40 mg three times a day to 320 mg three times a day, either alone or in combination with digoxin. Resting ECG was recorded and supine and standing blood pressures were measured on each dose level. When the patients were treated with verapamil alone, only a slight decrease in heart rate was noted, while during combined treatment with verapamil and digoxin a more marked heart rate decrease occurred with increasing doses of verapamil. The variation coefficient of the RR interval, a sign of ventricular regularity, decreased during verapamil treatment regardless of whether or not digoxin was also taken. A dose‐dependent blood pressure decrease was noted during verapamil treatment.</jats:p><jats:p>Side effects were common and led to discontinuation of the attempted protocol in all patients. Three patients were unexpectedly converted to stable sinus rhythm. Five patients improved subjectively, with a marked decrease in the sensation of palpitations during intake of increasing doses of verapamil. The study indicates that chronic oral treatment with verapamil may sometimes relieve the subjective sensation of palpitations in patients with atrial fibrillation. Side effects do, however limit the value of this mode of treatment in the majority of patients.</jats:p> |
| container_issue |
3 |
| container_start_page |
163 |
| container_title |
Clinical Cardiology |
| container_volume |
7 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792336626871959560 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T15:02:46.715Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Long%E2%80%90term+oral+treatment+with+high+doses+of+verapamil+in+lone+atrial+fibrillation&rft.date=1984-03-01&genre=article&issn=1932-8737&volume=7&issue=3&spage=163&epage=170&pages=163-170&jtitle=Clinical+Cardiology&atitle=Long%E2%80%90term+oral+treatment+with+high+doses+of+verapamil+in+lone+atrial+fibrillation&aulast=Bertil+OLSSON&aufirst=S.&rft_id=info%3Adoi%2F10.1002%2Fclc.4960070306&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792336626871959560 |
| author | Johansson, P.‐A., Bertil OLSSON, S. |
| author_facet | Johansson, P.‐A., Bertil OLSSON, S., Johansson, P.‐A., Bertil OLSSON, S. |
| author_sort | johansson, p.‐a. |
| container_issue | 3 |
| container_start_page | 163 |
| container_title | Clinical Cardiology |
| container_volume | 7 |
| description | <jats:title>Abstract</jats:title><jats:p>It has earlier been shown that verapamil given intravenously or orally in sufficiently high single doses, may result in regular ventricular rhythm in patients with atrial fibrillation. We have analyzed whether this effect of verapamil can be utilized in long‐term oral treatment. Eleven patients with lone atrial fibrillation were studied. Verapamil was given in gradually increasing doses from 40 mg three times a day to 320 mg three times a day, either alone or in combination with digoxin. Resting ECG was recorded and supine and standing blood pressures were measured on each dose level. When the patients were treated with verapamil alone, only a slight decrease in heart rate was noted, while during combined treatment with verapamil and digoxin a more marked heart rate decrease occurred with increasing doses of verapamil. The variation coefficient of the RR interval, a sign of ventricular regularity, decreased during verapamil treatment regardless of whether or not digoxin was also taken. A dose‐dependent blood pressure decrease was noted during verapamil treatment.</jats:p><jats:p>Side effects were common and led to discontinuation of the attempted protocol in all patients. Three patients were unexpectedly converted to stable sinus rhythm. Five patients improved subjectively, with a marked decrease in the sensation of palpitations during intake of increasing doses of verapamil. The study indicates that chronic oral treatment with verapamil may sometimes relieve the subjective sensation of palpitations in patients with atrial fibrillation. Side effects do, however limit the value of this mode of treatment in the majority of patients.</jats:p> |
| doi_str_mv | 10.1002/clc.4960070306 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9jbGMuNDk2MDA3MDMwNg |
| imprint | Wiley, 1984 |
| imprint_str_mv | Wiley, 1984 |
| institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1, DE-L229 |
| issn | 0160-9289, 1932-8737 |
| issn_str_mv | 0160-9289, 1932-8737 |
| language | English |
| last_indexed | 2024-03-01T15:02:46.715Z |
| match_str | johansson1984longtermoraltreatmentwithhighdosesofverapamilinloneatrialfibrillation |
| mega_collection | Wiley (CrossRef) |
| physical | 163-170 |
| publishDate | 1984 |
| publishDateSort | 1984 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | Clinical Cardiology |
| source_id | 49 |
| spelling | Johansson, P.‐A. Bertil OLSSON, S. 0160-9289 1932-8737 Wiley Cardiology and Cardiovascular Medicine General Medicine http://dx.doi.org/10.1002/clc.4960070306 <jats:title>Abstract</jats:title><jats:p>It has earlier been shown that verapamil given intravenously or orally in sufficiently high single doses, may result in regular ventricular rhythm in patients with atrial fibrillation. We have analyzed whether this effect of verapamil can be utilized in long‐term oral treatment. Eleven patients with lone atrial fibrillation were studied. Verapamil was given in gradually increasing doses from 40 mg three times a day to 320 mg three times a day, either alone or in combination with digoxin. Resting ECG was recorded and supine and standing blood pressures were measured on each dose level. When the patients were treated with verapamil alone, only a slight decrease in heart rate was noted, while during combined treatment with verapamil and digoxin a more marked heart rate decrease occurred with increasing doses of verapamil. The variation coefficient of the RR interval, a sign of ventricular regularity, decreased during verapamil treatment regardless of whether or not digoxin was also taken. A dose‐dependent blood pressure decrease was noted during verapamil treatment.</jats:p><jats:p>Side effects were common and led to discontinuation of the attempted protocol in all patients. Three patients were unexpectedly converted to stable sinus rhythm. Five patients improved subjectively, with a marked decrease in the sensation of palpitations during intake of increasing doses of verapamil. The study indicates that chronic oral treatment with verapamil may sometimes relieve the subjective sensation of palpitations in patients with atrial fibrillation. Side effects do, however limit the value of this mode of treatment in the majority of patients.</jats:p> Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation Clinical Cardiology |
| spellingShingle | Johansson, P.‐A., Bertil OLSSON, S., Clinical Cardiology, Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation, Cardiology and Cardiovascular Medicine, General Medicine |
| title | Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation |
| title_full | Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation |
| title_fullStr | Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation |
| title_full_unstemmed | Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation |
| title_short | Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation |
| title_sort | long‐term oral treatment with high doses of verapamil in lone atrial fibrillation |
| title_unstemmed | Long‐term oral treatment with high doses of verapamil in lone atrial fibrillation |
| topic | Cardiology and Cardiovascular Medicine, General Medicine |
| url | http://dx.doi.org/10.1002/clc.4960070306 |